Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria.
S Moñino-RomeroMan HuT OhanyanZ SzépfalusiKarsten WellerMartin MetzJ ScheffelMarcus MaurerS AltrichterPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Elevated sFcεRI serum levels predict early and good response to treatment with omalizumab, which may help to better design treatment options for CSU patients.